59 results on '"Ilaria Loperto"'
Search Results
2. Mode of discharge in CoViD-19 era: the case of the C.O.U. Oncology of 'San Giovanni di Dio e Ruggi d'Aragona' University Hospital
- Author
-
Rossella Alfano, Ilaria Loperto, Arianna Scala, Teresa Angela Trunfio, Andrea Lombardi, Anna Borrelli, Maria Triassi, Giovanni Improta, Alfano, R., Loperto, I., Scala, A., Trunfio, T. A., Lombardi, A., Borrelli, A., Triassi, M., and Improta, G.
- Subjects
Oncology ,Statistical analysis ,Covid-19 - Abstract
Background. The Covid-19 pandemic has deeply impacted the oncology community. The European Society for Medical Oncology (ESMO) suggests strengthening telemedicine services, reducing clinic visits and switching to subcutaneous or oral, rather than intravenous, therapies whenever possible. Methods. This study was conducted at the Oncology Complex Operating Unit by collecting data on all patients who accessed in 2019-2020. The aim was to understand how Covid-19 affected hospital admissions. Statistical tests and Logistic Regression were implemented. Results. The statistical analysis carried out showed that between 2019 and 2020 there was less use of emergency admission and voluntary discharge, while highlighting the increase in the "Protected with integrated home care"discharge mode. Conclusion. The results show how the European guidelines have improved the health process, from admission with the reduction of emergencies to discharge.
- Published
- 2022
- Full Text
- View/download PDF
3. Healthcare resource utilization and costs for extended interval dosing of natalizumab in multiple sclerosis
- Author
-
Marcello Moccia, Ilaria Loperto, Laura Santoni, Silvia Masera, Giuseppina Affinito, Antonio Carotenuto, Roberta Lanzillo, Maria Triassi, Vincenzo Brescia Morra, Raffaele Palladino, Moccia, Marcello, Loperto, Ilaria, Santoni, Laura, Masera, Silvia, Affinito, Giuseppina, Carotenuto, Antonio, Lanzillo, Roberta, Triassi, Maria, Morra, Vincenzo Brescia, and Palladino, Raffaele
- Subjects
Adult ,Multiple Sclerosis ,Natalizumab ,Leukoencephalopathy, Progressive Multifocal ,healthcare ,Middle Aged ,dosing ,Young Adult ,Immunologic Factor ,Multiple Sclerosis, Relapsing-Remitting ,Retrospective Studie ,multiple sclerosi ,cost ,Humans ,Immunologic Factors ,Female ,Neurology (clinical) ,Delivery of Health Care ,Sudden Infant Death ,Human ,Retrospective Studies - Abstract
Aims: Natalizumab is approved as an infusion every 4 weeks (standard-interval dosing [SID]) in relapsing-remitting multiple sclerosis (MS). Extended-interval dosing (EID) reduces risk of progressive multifocal leukoencephalopathy (PML) compared with SID, but the impact on healthcare resources and costs remains unknown. Methods: In this population-based study, we included 208 natalizumab-treated MS patients who were classified into EID (≤15 infusions in the previous 18 months; n = 51; age = 33.7 ± 11.1 years; female = 72.5%) and SID (>15 infusions in the previous 18 months; n = 157; age = 36.5 ± 10.8 years; female = 68.1%) groups. Results: Natalizumab EID had fewer MS outpatient visits (p = 0.01) and related costs (p = 0.03), and lower natalizumab costs (p
- Published
- 2022
4. Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: a population-based study in the Campania region (southern Italy)
- Author
-
Ilaria Loperto, Antonio Carotenuto, Marcello Moccia, Antonio Capacchione, Vincenzo Brescia Morra, Raffaele Palladino, Maria Triassi, Roberta Lanzillo, Moccia, M., Loperto, I., Lanzillo, R., Capacchione, A., Carotenuto, A., Triassi, M., Brescia Morra, V., and Palladino, R.
- Subjects
Male ,1110 Nursing ,Health administration ,Persistence (computer science) ,0302 clinical medicine ,Pegylated interferon ,Health care ,030212 general & internal medicine ,PREDICTORS ,GLATIRAMER ACETATE ,RISK ,education.field_of_study ,Health Policy ,lcsh:Public aspects of medicine ,Middle Aged ,INSIGHTS ,Italy ,DISEASE-MODIFYING THERAPIES ,Health Policy & Services ,Costs and Cost Analysis ,Health Resources ,Interferon ,Female ,BURDEN ,Life Sciences & Biomedicine ,medicine.drug ,Research Article ,Adult ,medicine.medical_specialty ,EUROPE ,Cost ,Population ,1117 Public Health and Health Services ,Medication Adherence ,Multiple sclerosis ,03 medical and health sciences ,Internal medicine ,Healthcare resource utilization ,medicine ,Humans ,COHORT ,Formulary ,Medical prescription ,education ,Retrospective Studies ,Science & Technology ,business.industry ,lcsh:RA1-1270 ,Interferon-beta ,medicine.disease ,EFFICACY ,Costs ,Health Care Sciences & Services ,business ,030217 neurology & neurosurgery ,0807 Library and Information Studies - Abstract
Background To differentiate five formulations of Interferon Beta for the treatment of multiple sclerosis (MS) in clinical practice, by analysing persistence, adherence, healthcare resource utilisation and costs at population level. Methods In this population-based study, we included individuals with MS living in the Campania Region of Italy from 2015 to 2017, on treatment with intramuscular Interferon Beta-1a (Avonex® = 618), subcutaneous pegylated Interferon Beta-1a (Plegridy® = 259), subcutaneous Interferon Beta-1a (Rebif® = 1220), and subcutaneous Interferon Beta-1b (Betaferon® = 348; and Extavia® = 69). We recorded healthcare resource utilisation from administrative databases (hospital discharges, drug prescriptions, MS-related outpatients), and derived costs from the Regional formulary. We classified hospital admissions into MS-related and non-MS-related. Persistence (time to switch to other disease modifying treatments (DMTs)), and adherence (medication possession ratio (MPR) = medication supply obtained/medication supply expected during follow-up period) were calculated. Results Patients treated with Rebif® were younger, when compared with other Interferon Beta formulations (p p p p = 0.03), when compared with Rebif®. The probability of MS-related hospital admissions was 40% higher in Avonex® (p = 0.03), 400% higher in Betaferon® (p p = 0.04), resulting into higher non-DMT-related costs, when compared with Rebif®. Discussion Interferon Beta formulations presented with different prescription patterns, persistence, adherence, healthcare resource utilisation and costs, with Rebif® being used in younger patients and with less MS-related hospital admissions.
- Published
- 2020
- Full Text
- View/download PDF
5. COVID19 Pandemic and Physical Activity: An Observational Study on Sleep Quality and Anxiety
- Author
-
Ausilia Elce, Aurora Daniele, Ilaria Loperto, Lucia De Coppi, Armando Sangiorgio, Angelina Vivona, Clorinda Sorrentino, Simona Iannaccone, Lucia Martiniello, Ersilia Nigro, Elce, Ausilia, Daniele, Aurora, Loperto, Ilaria, De Coppi, Lucia, Sangiorgio, Armando, Vivona, Angelina, Sorrentino, Clorinda, Iannaccone, Simona, Martiniello, Lucia, and Nigro, Ersilia
- Subjects
education ,COVID-19 pandemic ,physical activity ,Physical Therapy, Sports Therapy and Rehabilitation ,Orthopedics and Sports Medicine ,sleep ,professional athlete ,mental health - Abstract
Mental alterations were described during the COVID-19 pandemic and sleep deprivation has been reported as a consequence of social isolation. In Italy, the COVID-19 pandemic spread out at the beginning of 2020 determining severe lockdown periods. The aim of our study was to observe the effects of lockdown on sleep and anxiety in trained non-professional subjects and professional athletes who continued to train during the lockdown period. Forty-six subjects (21 trained non-professional subjects and 25 professional athletes) were recruited from a variety of team and individual sports to complete a battery of previously validated and widely used questionnaires assessing psychometric and anthropometric parameters, physical activity levels, lifestyle habits, and sleep quality. Subjects were aged 27.0 ± 5.14. All items were evaluated as percentages and chi-square and Fisher’s exact tests were performed, as appropriate. Our data showed that the prevalence of the difficulty of falling asleep (over 30%), the tendency of nocturnal awakenings (over 30%), and moderate anxiety (over 38%) were at the same extent in the two groups. Of the professional athletes, 72.73% declared snoring during sleep vs 42.86% of non-professional subjects. No other significant differences were found between the two groups except for the perception of being constant in daily activity, significantly more reported by trained subjects (p < 0.005). Our data show a similar scenario of anxiety and sleep disturbances for the two groups, suggesting that lockdown by the COVID-19 pandemic has partially mitigated the known beneficial effects due to physical activity on mental health and sleep quality. Further analyses are necessary to define the associated risk factors.
- Published
- 2022
6. Safety and Immunogenicity of Anti-SARS-CoV-2 Booster Dose in Patients with Chronic Liver Disease
- Author
-
Valentina Cossiga, Mario Capasso, Maria Guarino, Ilaria Loperto, Stefano Brusa, Francesco Maria Cutolo, Maria Rosaria Attanasio, Raffaele Lieto, Giuseppe Portella, and Filomena Morisco
- Subjects
COVID-19 ,SARS-CoV-2 ,chronic liver disease ,vaccine ,cirrhosis ,General Medicine - Abstract
The low response to vaccines is a well-known problem in cirrhosis. We evaluated the safety and immunogenicity of booster doses in patients with chronic liver disease (CLD), comparing the humoral response in cirrhotic vs. non-cirrhotic patients, and the impact of different factors on immune response. From September 2021 to April 2022, outpatients with CLD who completed the primary vaccination course and the booster dose against SARS-CoV-2 were enrolled. Blood samples were collected after second and third doses for detecting anti-spike protein IgG. We enrolled 340 patients; among them, 91 subjects were cirrhotic. After primary vaccination course, 60 (17.6%) patients did not develop a positive antibody titer, without significant differences between cirrhotic and non-cirrhotic patients (p = 0.076); most of them (88.3%) developed it after booster dose. At multivariable analysis, factors associated with higher humoral response after booster dose were only porto-sinusoidal vascular disorder (p = 0.007) as an etiology of CLD and the use of the mRNA-1273 vaccine (p = 0.001). In conclusion, in patients with CLD, a booster dose against SARS-CoV-2 induces an excellent immunogenicity and leads to an adequate antibody response. Cirrhosis is not associated with a worse humoral response, compared to patients with non-cirrhotic CLD.
- Published
- 2023
- Full Text
- View/download PDF
7. The Impact of CoViD-19 on hospital activities: the case of the C.O.U. Otorhinolaryngology
- Author
-
Ilaria Loperto, Rossella Alfano, Arianna Scala, Giuseppe Ferrucci, Anna Borrelli, Teresa Angela Trunfio, and Paolo Gargiulo
- Published
- 2021
- Full Text
- View/download PDF
8. COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study
- Author
-
Maria Guarino, Valentina Cossiga, Ilaria Loperto, Ilaria Esposito, Rosanna Ortolani, Andrea Fiorentino, Giuseppina Pontillo, Lucia De Coppi, Valentina Cozza, Alfonso Galeota Lanza, Giovanni Giuseppe Di Costanzo, Francesco Paolo Picciotto, Filomena Morisco, Guarino, Maria, Cossiga, Valentina, Loperto, Ilaria, Esposito, Ilaria, Ortolani, Rosanna, Fiorentino, Andrea, Pontillo, Giuseppina, De Coppi, Lucia, Cozza, Valentina, Galeota Lanza, Alfonso, Di Costanzo, Giovanni Giuseppe, Picciotto, Francesco Paolo, and Morisco, Filomena
- Subjects
Adult ,Hospitalization ,Male ,Multidisciplinary ,SARS-CoV-2 ,Incidence ,COVID-19 ,Humans ,Female ,Prospective Studies ,Middle Aged ,Liver Transplantation - Abstract
Liver transplant (LT) recipients are vulnerable to SARS-CoV-2-infection (COVID-19), due to immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID-19 on LT recipients compared to general population in the Campania region. In this prospective double-centre study, we enrolled all consecutive adult LT recipients with confirmed SARS-CoV-2-infection. Data were collected at diagnosis of COVID-19 and during follow-up and compared with the regional population. Thirty LT recipients (3.28%) developed SARS-CoV-2-infection (76.66% male, median age 62.61 years). Sixteen (53.33%) were symptomatic. Common symptoms were fever, cough, fatigue, and anosmia. Twenty-five (83.33%) were outpatients, 5 (16.66%) required hospitalization (6.66% admitted to Intensive Care Unit, 6.62% developed Acute Respiratory Distress Syndrome and 6.66% died). Immunosuppressors were in 3 (10%) patients. Incidence rate of COVID-19 was similar between LT patients and general population (3.28% vs 4.37%, p = 0.142) with higher rate of symptoms in LT patients (53.33% vs 15.87%, p
- Published
- 2021
9. Covid-19 in Liver Transplant Recipients: An Italian Case-Control Double-Centre Study
- Author
-
Maria Guarino, Valentina Cossiga, Ilaria Loperto, Ilaria Esposito, Rosanna Ortolani, Andrea Fiorentino, Giuseppina Pontillo, Lucia De Coppi, Valentina Cozza, Alfonso Galeota Lanza, Giovanni Giuseppe Di Costanzo, Francesco Paolo Picciotto, and Filomena Morisco
- Abstract
Background and Aims: Liver transplant (LT) recipients are vulnerable to SARS-CoV-2-infection (COVID-19), due to immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID-19 on LT recipients compared to general population in the Campania region.Methods: In this case-control double-centre study, we enrolled all consecutive adult LT recipients with confirmed SARS-CoV-2-infection. Data were collected at diagnosis of COVID-19 and during follow-up and compared with the regional population. Results: Thirty LT recipients (3.28%) developed SARS-CoV-2-infection (76.6% male, median age 62.6 years). Sixteen (53.3%) were symptomatic. Common symptoms were fever, cough, fatigue, and anosmia. Twenty-five (83.4%) were outpatients, 5 (16.6%) required hospitalization (6.6% admitted to Intensive Care Unit, 6.6% developed Acute Respiratory Distress Syndrome and 6.6% died). Immunosuppressors were in 3 (10%) patients. Incidence rate of COVID-19 was similar between LT patients and general population (3.28% vs 4.37%, p=0.1) with higher rate of symptoms in LT patients (46.67% vs 15.87%, pConclusions: LT is not a risk factor for acquiring COVID-19. Nonetheless, LT patients are more frequently symptomatic, although comparable to the general population for hospitalization rate and mortality.
- Published
- 2021
- Full Text
- View/download PDF
10. Use of regression models to predict glomerular filtration rate in kidney transplanted patients
- Author
-
Ilaria Loperto, Arianna Scala, Lucia Rossano, Rosa Carrano, Stefano Federico, Maria Triassi, Giovanni Improta, Loperto, Ilaria, Scala, Arianna, Rossano, Lucia, Carrano, Rosa, Federico, Stefano, Triassi, Maria, and Improta, Giovanni
- Published
- 2021
- Full Text
- View/download PDF
11. The study of variation in the Diagnostic Related Group Weight in a Complex Operative Units of Paediatrics and Paediatric Surgery due to CoViD-19 pandemic
- Author
-
Ilaria Loperto, Anna Borrelli, Andrea Lombardi, and Maria Triassi
- Published
- 2021
- Full Text
- View/download PDF
12. Analysis of the adequacy of admissions in a Complex Operative Unit of General Surgery and Day Surgery and Breast Unit
- Author
-
Ilaria Loperto, Arianna Scala, Anna Borrelli, Giovanni Rossi, and Maria Triassi
- Published
- 2021
- Full Text
- View/download PDF
13. Use of statistical analysis and logistic regression to study the length of stay in an Emergency Medicine Department in CoViD-19 era
- Author
-
Ilaria Loperto, Lucia De Coppi, Arianna Scala, Anna Borrelli, Giuseppe Ferrucci, and Maria Triassi
- Published
- 2021
- Full Text
- View/download PDF
14. Investigating the impact of CoViD-19 on the activities of a Department of General Medicine
- Author
-
Arianna Scala, Lucia De Coppi, Ilaria Loperto, Anna Borrelli, Andrea Lombardi, and Maria Triassi
- Published
- 2021
- Full Text
- View/download PDF
15. Hospital activities and CoViD-19: the case study of a Urology Department
- Author
-
Ilaria Loperto, Anna Borrelli, Michele Sparano, and Maria Triassi
- Published
- 2021
- Full Text
- View/download PDF
16. Using Statistical Analysis and Logistic Regression to study the effect of CoViD-19 on hospital activities of the C.O.U. General Surgery and Kidney Transplants
- Author
-
Rossella Alfano, Ilaria Loperto, Teresa Angela Trunfio, Cristiana Giglio, Giovanni Rossi, Anna Borrelli, Arianna Scala, and Paolo Gargiulo
- Published
- 2021
- Full Text
- View/download PDF
17. Risk Factors Analysis of Surgical Infection Using Artificial Intelligence: A Single Center Study
- Author
-
Arianna Scala, Ilaria Loperto, Maria Triassi, Giovanni Improta, Scala, A., Loperto, I., Triassi, M., and Improta, G.
- Subjects
sursgical site infection ,Risk Factor ,Health, Toxicology and Mutagenesis ,Public Health, Environmental and Occupational Health ,health informatic ,Antibiotic Prophylaxis ,Anti-Bacterial Agents ,Risk Factors ,Artificial Intelligence ,Anti-Bacterial Agent ,Humans ,Surgical Wound Infection ,Antibiotic Prophylaxi ,statistical software ,health informatics ,Human - Abstract
Background: Surgical site infections (SSIs) have a major role in the evolution of medical care. Despite centuries of medical progress, the management of surgical infection remains a pressing concern. Nowadays, the SSIs continue to be an important factor able to increase the hospitalization duration, cost, and risk of death, in fact, the SSIs are a leading cause of morbidity and mortality in modern health care. Methods: A study based on statistical test and logistic regression for unveiling the association between SSIs and different risk factors was carried out. Successively, a predictive analysis of SSIs on the basis of risk factors was performed. Results: The obtained data demonstrated that the level of surgery contamination impacts significantly on the infection rate. In addition, data also reveals that the length of postoperative hospital stay increases the rate of surgical infections. Finally, the postoperative length of stay, surgery department and the antibiotic prophylaxis with 2 or more antibiotics are a significant predictor for the development of infection. Conclusions: The data report that the type of surgery department and antibiotic prophylaxis there are a statistically significant predictor of SSIs. Moreover, KNN model better handle the imbalanced dataset (48 infected and 3983 healthy), observing highest accuracy value.
- Published
- 2022
- Full Text
- View/download PDF
18. Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients
- Author
-
Maria Guarino, Ilaria Esposito, Giuseppe Portella, Valentina Cossiga, Ilaria Loperto, Raffaella Tortora, Michele Cennamo, Mario Capasso, Daniela Terracciano, Alfonso Galeota Lanza, Sarah Di Somma, Francesco Paolo Picciotto, Filomena Morisco, Giuseppina Pontillo, Luca Pignata, Maria Rosaria Attanasio, Raffaele Lieto, Francesco Cutolo, and Marianna Cuomo
- Subjects
Adult ,Male ,OR, Odds Ratio ,COVID-19 Vaccines ,Antimetabolites ,BMI, body mass index ,Antibodies, Viral ,NAFLD, Non-Alcoholic fatty liver disease ,Article ,Humans ,RNA, Messenger ,BNT162 Vaccine ,Vaccines, Synthetic ,immunosuppression ,liver transplantation ,Hepatology ,SARS-CoV-2 ,Vaccination ,Gastroenterology ,COVID-19 ,Middle Aged ,Sars-CoV-2 vaccination ,Transplant Recipients ,95%CI, 95% confidence intervals ,Immunoglobulin G ,COVID-19, SARS-CoV-2 infection ,ALD, Alcoholic liver disease ,Female ,mRNA Vaccines ,HCC, hepatocellular carcinoma ,LT, liver transplant - Abstract
In the context of the Italian severe acute respiratory syndrome coronavirus 2 vaccination program, liver transplant (LT) recipients were prioritized for vaccine administration, although the lower response to vaccines is a well-known problem in this population. We aimed to evaluate immunogenicity of BNT162b2 mRNA vaccine in LT recipients and healthy controls and to identify factors associated with negative response to vaccine.In a cohort of adult patients with LT, we prospectively evaluated the humoral response (with anti-Spike protein IgG-LIAISON SARS-CoV-2 S1/S2-IgG chemiluminescent assay) at 1 and 3 months after 2-dose vaccination. A group of 307 vaccinated health care workers, matched by age and sex, served as controls.Overall, 492 LT patients were enrolled (75.41% male; median age, 64.85 years). Detectable antibodies were observed in the 75% of patients, with a median value of 73.9 AU/mL after 3 months from 2-dose vaccination. At multivariable analysis, older age (40 years; P = .016), shorter time from liver transplantation (5 years; P = .004), and immunosuppression with antimetabolites (P = .029) were significantly associated with non-response to vaccination. Moreover, the LT recipients showed antibody titers statistically lower than the control group (103 vs 261 AU/mL; P.0001). Finally, in both controls and LT patients, we found a trend of inverse correlation between age and antibody titers (correlation coefficients: -0.2023 and -0.2345, respectively).Three months after vaccination, LT recipients showed humoral response in 75% of cases. Older age, shorter time from transplantation, and use of antimetabolites were factors associated with non-response to vaccination, and LT recipients at risk of non-response to vaccination needed to be kept under close monitoring.
- Published
- 2022
- Full Text
- View/download PDF
19. Assessment of proteinuria level in nephrology patients using a machine learning approach
- Author
-
Ilaria Loperto, Rosa Carrano, Giovanni Improta, Stefano Federico, Arianna Scala, Maria Triassi, Scala, Arianna, Loperto, Ilaria, Carrano, Rosa, Federico, Stefano, Triassi, Maria, and Improta, Giovanni
- Subjects
Nephrology ,Blood level ,medicine.medical_specialty ,Proteinuria ,urogenital system ,business.industry ,urologic and male genital diseases ,medicine.disease ,Machine learning ,computer.software_genre ,Kidney transplant ,Glomerular capillary ,Urinary excretion ,Internal medicine ,Medicine ,In patient ,Artificial intelligence ,medicine.symptom ,business ,computer ,Kidney transplantation - Abstract
Proteinuria represents an increase in the urinary excretion of proteins. It could also follow kidney transplantation and affects more than 40% of kidney transplant patients per year. It results from protein increases in their filtered load, due to alterations in the selectivity of the glomerular capillary wall, or from defects in their tubular uptake. Different parameters are associated with the various stages of proteinuria and therefore allow characterizing of its severity. For this purpose, the variation of proteinuria was evaluated by loading input two parameters: glycemia and the blood level of the m-Tor inhibitor. Through combination of data with different machine learning algorithms, the goal of this research work was to evaluate how blood glucose values and the use of immunosuppressive drugs can lead to prediction proteinuria classification in patients.
- Published
- 2021
- Full Text
- View/download PDF
20. Multiple Regression and Machine Learning to investigate factors influencing the length of hospital stay after valvuloplasty
- Author
-
Giuseppe Cesarelli, Ilaria Loperto, Arianna Scala, Lucia Rossano, Anna Borrelli, and Antonietta Ferrara
- Subjects
Pediatrics ,medicine.medical_specialty ,Heart disease ,business.industry ,Incidence (epidemiology) ,valvular heart disease ,medicine.disease ,Valvular disease ,Progressive disorder ,Linear regression ,Medicine ,In patient ,business ,Hospital stay - Abstract
Valvular heart disease is a progressive disorder, which often requires surgery, principally when it is severe and/or the patient is symptomatic. Over the last 60 years the incidence of rheumatic heart disease has declined, but the number of valve surgeries performed did not follow such decrease in rheumatic incidence. In fact, important changes in patient characteristics and in the distribution of the type of valvular lesions are emerged. This valvular disease variation also increases operative risk and the length of hospital stay (LOS). Nowadays, multiple factors are associate to LOS, which indicates the sum of pre-operative and post-operative-LOS. In this study, Multiple linear regression (MLR) was used to discover a model that was able to predict LOS knowing characteristic of patients, and the factors that most affect LOS were evaluated.
- Published
- 2021
- Full Text
- View/download PDF
21. Lean Six Sigma Approach for Reducing Length of Hospital Stay for Patients with Femur Fracture in a University Hospital
- Author
-
Arianna Scala, Antonio Della Vecchia, Anna Borrelli, Giovanni Improta, Ilaria Loperto, Maria Triassi, Giuseppe Russo, Alfonso Maria Ponsiglione, Scala, A., Ponsiglione, A. M., Loperto, I., Della Vecchia, A., Borrelli, A., Russo, G., Triassi, M., and Improta, G.
- Subjects
Waiting time ,medicine.medical_specialty ,Health, Toxicology and Mutagenesis ,lcsh:Medicine ,healthcare quality ,Article ,03 medical and health sciences ,0302 clinical medicine ,process improvement ,length of stay ,0502 economics and business ,medicine ,Humans ,Femur ,030212 general & internal medicine ,Lean Six Sigma ,Aged ,Retrospective Studies ,Femur fracture ,business.industry ,05 social sciences ,DMAIC ,Gold standard ,lcsh:R ,public health ,Public Health, Environmental and Occupational Health ,University hospital ,Italy ,Emergency medicine ,business ,Hospital stay ,050203 business & management ,Total Quality Management - Abstract
Surgical intervention within 48 h of hospital admission is the gold standard procedure for the management of elderly patients with femur fractures, since the increase in preoperative waiting time is correlated with the onset of complications and longer overall length of stay (LOS) in the hospital. However, national evidence demonstrates that there is still the need to provide timely intervention for this type of patient, especially in some regions of central southern Italy. Here we discuss the introduction of a diagnostic–therapeutic assistance pathway (DTAP) to reduce the preoperative LOS for patients undergoing femur fracture surgery in a university hospital. A Lean Six Sigma methodology, based on the DMAIC cycle (Define, Measure, Analyze, Improve, Control), is implemented to evaluate the effectiveness of the DTAP. Data were retrospectively collected and analyzed from two groups of patients before and after the implementation of DTAP over a period of 10 years. The statistics of the process measured before the DTAP showed an average preoperative LOS of 5.6 days (standard deviation of 3.2), thus confirming the need for corrective actions to reduce the LOS in compliance with the national guidelines. The influence of demographic and anamnestic variables on the LOS was evaluated, and the impact of the DTAP was measured and discussed, demonstrating the effectiveness of the improvement actions implemented over the years and leading to a significant reduction in the preoperative LOS, which decreased to an average of 3.5 days (standard deviation of 3.60). The obtained reduction of 39% in the average LOS proved to be in good agreement with previously developed DTAPs for femur fracture available in the literature.
- Published
- 2021
- Full Text
- View/download PDF
22. Bodybuilding, dietary supplements and hormones use: behaviour and determinant analysis in young bodybuilders
- Author
-
Raffaele Nubi, Ilaria Loperto, Davide Castrianni, Paolo Montuori, Elvira De Rosa, Raffaele Palladino, Maria Triassi, Carmine Paolo, Montuori, P., Loperto, I., Paolo, C., Castrianni, D., Nubi, R., De Rosa, E., Palladino, R., and Triassi, M.
- Subjects
medicine.medical_specialty ,Sports medicine ,1106 Human Movement and Sports Sciences ,NUTRITIONAL SUPPLEMENTS ,EXERCISE ,Physical Therapy, Sports Therapy and Rehabilitation ,Logistic regression ,SPORTS ,Dietary supplement ,Athlete ,Statistical analyses ,Medicine ,Orthopedics and Sports Medicine ,DRUG ,Science & Technology ,Descriptive statistics ,Health professionals ,biology ,Athletes ,business.industry ,Public health ,Research ,Rehabilitation ,PERFORMANCE ,biology.organism_classification ,Dietary supplements ,PREVALENCE ,Diet ,Bodybuilding ,Gyms ,HEALTH ,business ,RC1200-1245 ,Life Sciences & Biomedicine ,Sport Sciences ,1199 Other Medical and Health Sciences ,Demography ,Hormone - Abstract
Background Among athletes, bodybuilders are more predisposed to the use of dietary supplements (DS) and hormones (H) to increase in adaptations to physical training and performance. The purpose of the study was to identify social, psychological, and organisational factors that are associated with the use of food supplements and hormones in young bodybuilders of the metropolitan area of Naples. Methods 107 athletes, practicing bodybuilding, were consecutively recruited in 30 gyms, randomly selected in the metropolitan area of Naples. Athletes were administered an anonymous questionnaire. The questionnaire consists of 5 sections (socio-demographic, frequency and reasons for bodybuilding, knowledge, attitudes and behaviours). Descriptive statistics were performed using T-test and Chi-square statistics. A score was created for knowledge, attitudes, behaviours. Multivariable logistic regression models were employed to assess association between each score and the use of DS and H. Statistical analyses were carried out using STATA 15. Results 81.31% of the subjects reported to use DS while 35.51% H. Females are less likely to practise bodybuilding frequently than males (OR 0.18 (95% CI 0.05–0.69), p = 0.01). Subjects who have attended high school or university have a lower probability of taking DS (OR 0.17 (95% CI 0.04–0.65), p = 0.01). H users also use supplements more frequently (OR 61.21 (95% CI 3.99–939.31), p Conclusions Prevalence of H and DS’ use, although lower than reported in the literature, is a worrying public health problem. Better knowledge can lead to an informed use. Gym instructors should be trained to provide accurate and scientifically sound information. Health professionals should combine their expertise to provide more comprehensive guidance to the exercisers.
- Published
- 2021
23. Symptoms of mental health problems among Italian adolescents in 2017–2018 school year: a multicenter cross-sectional study
- Author
-
Maria Triassi, Elena Raffetti, Alessia Maccaro, Elia Croce, Ilaria Loperto, Sara Mentasti, Federica Crivillaro, Antonella Elvetico, Francesco Donato, Donato, Francesco, Triassi, Maria, Loperto, Ilaria, Maccaro, Alessia, Mentasti, Sara, Crivillaro, Federica, Elvetico, Antonella, Croce, Elia, and Raffetti, Elena
- Subjects
Male ,medicine.medical_specialty ,Adolescent ,Cross-sectional study ,Logistic regression ,Odds ,Smoking behavior ,03 medical and health sciences ,Screen time ,0302 clinical medicine ,030225 pediatrics ,Environmental health ,Humans ,Medicine ,030212 general & internal medicine ,Students ,Psychiatric Status Rating Scales ,Schools ,business.industry ,Mental Disorders ,Public health ,Public Health, Environmental and Occupational Health ,Bullying ,Social environment ,General Medicine ,Mental health ,mental health, adolescents ,Cross-Sectional Studies ,Behaviors ,Risk factors ,Social context ,Female ,Italy ,Risk Factors ,Adolescent Behavior ,business ,Research Article - Abstract
Background Identifying individual and contextual factors that influence adolescent well-being is a research priority. This study aimed to assess the prevalence of symptoms of mental health problems and some related factors in Italian adolescents in 2017–2018. Methods The present study was a cross-sectional survey among 3002 students aged 15–16 years who resided in two Italian provinces, in North and South Italy. Symptoms of mental health problems were assessed using the SDQ and CES-DC, and students’ risk-taking behaviors and school climate perception were assessed. All information was collected anonymously. Logistic regression models were used to assess the associations of tobacco and alcohol use, screen time, bullying, and school climate with symptoms of mental health problems. Results One student out of five reported symptoms of mental health problems, with a more than double proportion among girls than boys (28.7% vs 10.4% with depressive symptoms, respectively). Thirty percent and 40% of students smoked tobacco or drank alcoholic beverages at least once in the past month, and more than 40% reported being victims or authors of bullying in the past 6 months. Smoking behavior, alcohol consumption, screen time, bullying, and negative school climate had 1.2- to 3.3-fold increased odds of symptoms of mental health problems without substantial differences between sexes and geographical areas. Conclusions Tobacco and alcohol use, screen time, bullying, and school climate were independently associated with symptoms of mental health problems in a large sample of 15–16-year-old Italian adolescents without substantial gender and geographical differences.
- Published
- 2021
24. Appropriate admission in Covid-19 era: the case study of the C.O.U. Neurology and Stroke Unit
- Author
-
Ilaria Loperto, Arianna Scala, Rossella Alfano, Teresa Angela Trunfio, Cristiana Giglio, Giovanni Rossi, Anna Borrelli, Maria Triassi, Giovanni Improta, Loperto, Ilaria, Scala, Arianna, Alfano, Rossella, Trunfio, TERESA ANGELA, Giglio, Cristiana, Rossi, Giovanni, Borrelli, Anna, Triassi, Maria, and Improta, Giovanni
- Published
- 2021
25. Investigation of the risk of surgical infections at the 'federico II' University Hospital by regression analysis using the firth method
- Author
-
Emma Montella, Ilaria Loperto, Michela Pietrantonio, Vincenza Colucci, Maria Triassi, Alfonso Maria Ponsiglione, Montella, E., Loperto, I., Pietrantonio, M., Colucci, V., Triassi, M., and Ponsiglione, A. M.
- Subjects
Public health ,Surgical infections ,Healthcare associated infection ,Logistic regression ,Biomedical data analysi - Abstract
Surgical infections (SSIs) are among the most common type of healthcare associated infections (HAIs) and a major cause of morbidity among surgical patients, increase of hospitalization days and of healthcare expenditure In this work, we present a logistic regression model to study the impact that different clinical, demographic and organizational factors have on the risk of occurrence of HAIs in a surgery department. The proposed model regression model is based on the Firth's penalized maximum likelihood logistic regression, a well-suited methodology for the analysis of unbalanced datasets, such as those related to events with a low occurrence rate, which is often the case of hospital infections. The model proved to be able to identify the factors most influencing the risk of SSIs and offers a promising tool for the systematic study of SSIs.
- Published
- 2021
26. Liquid biopsy in lung cancer: tertiary prevention potential
- Author
-
Giancarlo Troncone, Ilaria Loperto, R Egidio, A Iervolino, Umberto Malapelle, F. Rubba, T De Pascale, Francesco Pepe, Maria Triassi, and R Martello
- Subjects
medicine.medical_specialty ,business.industry ,Public Health, Environmental and Occupational Health ,Cancer ,medicine.disease ,Tissue specimen ,Tumor progression ,medicine ,Molecular diagnostic techniques ,Radiology ,Liquid biopsy ,Lung cancer ,business ,Tertiary Prevention - Abstract
Background In the era of personalized therapy liquid biopsy is considered an important diagnostic tool in the clinical management of cancer patients. Tissue specimen represents “gold standard” for molecular evaluation of specific gene targets alterations that lead cancer patients to benefit of a “tailed therapy” based on molecular features of the tumor. This innovative source of nucleic acids was introduced in clinical setting only for NSCLC patients to test Epidermal Grow Factor Receptor (EGFR) mutations when tissue is not available or to monitor acquired resistance mutation after a first line of treatment. The study aimed at assessing the diagnostic potential of liquid biopsy in balanced tertiary screening modeling. Methods The cases relating to 5 years of activity regarding to molecular diagnostics performed on liquid biopsy specimens in the Predictive Diagnostic laboratory of AOU Federico II were reviewed. Laboratory data were collected in SPSS. Non parametric analysis were performed in order to test the differences between patients WILD TYPE or not. A multivariate logistic model was performed in order to assess the effect of mutation, age and sex, on the tumor progression. The results of the revision concern 515 total cases (almost of all plasma or peripheral blood) allowed to evaluate the liquid biopsies for women and men. The average age of the Patients is 66.3 years, and the 25 percentile is 59 years. Results The cases are 221 basal and 294 by progression. The cases with mutation, as expected, have an OR 4,15 compared to the basal to have a tumor progression (95% IC: 2,7 - 6,3) regardless of sex and age. The mutations detected were 131 from different types of pulmonary carcinomas. Conclusions Working on case data, specifying the characteristics of the Patients with mutations will drive a further estimate in tertiary prevention screening designs. Key messages In the last five years, the liquid biopsy has been used for different purposes in oncology. To specify the characteristics of the Patients with mutations will drive a further estimate in tertiary prevention screening designs.
- Published
- 2020
- Full Text
- View/download PDF
27. [Liquid biopsy as indication of tumour progression in lung cancer: a potential intervention in tertiary prevention]
- Author
-
Umberto, Malapelle, Francesco, Pepe, Pasquale, Pisapia, Ilaria, Loperto, Marina Silvia, Scamardo, Rosanna, Egidio, Teresa, De Pascale, Adriano, De Vita, Maria, Triassi, Giancarlo, Troncone, and Fabiana, Rubba
- Subjects
Adult ,Male ,Lung Neoplasms ,Italy ,Carcinoma, Non-Small-Cell Lung ,Liquid Biopsy ,Tertiary Prevention ,Humans ,Female ,Middle Aged ,Aged - Abstract
In the era of personalised therapies, liquid biopsy is considered an important diagnostic tool in the clinical management of cancer patients. Tissue specimen represents the gold standard for molecular evaluation of specific gene targets alterations that lead cancer patients to benefit of a "tailed therapy" based on molecular features of the tumour. This innovative source of nucleic acids was introduced in clinical setting only for non-small-cell lung cancer (NSCLC) patients to test epidermal grow factor receptor (EGFR) mutations when tissue is not available for a number of reasons (difficult access to the lesion, the presence of other disabling pathologies, especially in elderly patients, rejection by the patient, etcetera) or to monitor acquired resistance mutation after a first line of treatment. The present study aimed at assessing the diagnostic potential of liquid biopsy in balanced tertiary screening modelling. The cases relating to 5 years of activity regarding to molecular diagnostics performed on liquid biopsy specimens in the Predictive diagnostic laboratory of the University hospital "Federico II" of Naples (Campania Region, Southern Italy) were reviewed. Laboratory data were collected through the software SPSS. Non-parametric analysis was performed in order to test the differences between "wild type" patients or not. A multivariate logistic model was performed in order to assess the effect of mutation, age, and gender on the tumour progression. The results of the revision concern 515 total cases (almost of all plasma or peripheral blood), which allowed to evaluate the liquid biopsies for women and men. The average age of the patients is 66.3 years, and the 25° percentile is 59 years. The cases are: 221 basal and 294 by progression. The cases with mutation, as expected, have an odds ratio of 4,15, compared to the basal, to have a tumour progression (95%IC 2,7-6,3), regardless of gender and age. The detected mutations were 131 from different types of pulmonary carcinomas. Working on case data, specifying the characteristics of the patients with mutations will drive a further estimate in tertiary prevention screening designs.
- Published
- 2020
28. Multiple Sclerosis in the Campania Region (South Italy): Algorithm Validation and 2015–2017 Prevalence
- Author
-
Maria Pia Sormani, Nicola Capasso, Vincenzo Brescia Morra, Martina Petruzzo, Marcello Moccia, Raffaele Palladino, Roberta Lanzillo, Ilaria Loperto, Maria Grazia Fumo, Maria Triassi, Roberta Giordana, Moccia, Marcello, Brescia Morra, Vincenzo, Lanzillo, Roberta, Loperto, Ilaria, Giordana, Roberta, Fumo, Maria Grazia, Petruzzo, Martina, Capasso, Nicola, Triassi, Maria, Sormani, Maria Pia, and Palladino, Raffaele
- Subjects
Male ,Multiple Sclerosis ,Health, Toxicology and Mutagenesis ,prevalence ,Prevalence ,lcsh:Medicine ,Environmental Sciences & Ecology ,Toxicology ,Article ,03 medical and health sciences ,0302 clinical medicine ,Medicine ,Humans ,Clinical registry ,030212 general & internal medicine ,Medical prescription ,Healthcare data ,Public, Environmental & Occupational Health ,Retrospective Studies ,OUTCOMES ,Science & Technology ,business.industry ,Multiple sclerosis ,lcsh:R ,Public Health, Environmental and Occupational Health ,medicine.disease ,INSIGHTS ,SIZE ,Italy ,multiple sclerosi ,routinely collected healthcare data ,Cohort ,Female ,Routinely collected healthcare data ,business ,Algorithm ,Life Sciences & Biomedicine ,030217 neurology & neurosurgery ,Environmental Sciences ,Algorithms - Abstract
We aim to validate a case-finding algorithm to detect individuals with multiple sclerosis (MS) using routinely collected healthcare data, and to assess the prevalence of MS in the Campania Region (South Italy). To identify individuals with MS living in the Campania Region, we employed an algorithm using different routinely collected healthcare administrative databases (hospital discharges, drug prescriptions, outpatient consultations with payment exemptions), from 1 January 2015 to 31 December 2017. The algorithm was validated towards the clinical registry from the largest regional MS centre (n = 1460). We used the direct method to standardise the prevalence rate and the capture-recapture method to estimate the proportion of undetected cases. The case-finding algorithm including individuals with at least one MS record during the study period captured 5362 MS patients (females = 64.4%, age = 44.6 ±, 12.9 years), with 99.0% sensitivity (95% CI = 98.3%, 99.4%). Standardised prevalence rate per 100,000 people was 89.8 (95% CI = 87.4, 92.2) (111.8 for females [95% CI = 108.1, 115.6] and 66.2 for males [95% CI = 63.2, 69.2]). The number of expected MS cases was 2.7% higher than cases we detected. We developed a case-finding algorithm for MS using routinely collected healthcare data from the Campania Region, which was validated towards a clinical dataset, with high sensitivity and low proportion of undetected cases. Our prevalence estimates are in line with those reported by international studies conducted using similar methods. In the future, this cohort could be used for studies with high granularity of clinical, environmental, healthcare resource utilisation, and pharmacoeconomic variables.
- Published
- 2020
29. Knowledge and beliefs on vaccines among a sample of Italian pregnant women: results from the NAVIDAD study
- Author
-
Fabrizio, Bert, Elena, Olivero, Paola, Rossello, Maria, R Gualano, Silvana, Castaldi, Gianfranco, Damiani, Marcello, M D’Errico, Pamela Di Giovanni, Maria, P Fantini, Leila, Fabiani, Giovanni, Gabutti, Ilaria, Loperto, Marina, Marranzano, Giuseppe, Masanotti, Nicola, Nante, Rosso, Annalisa, Raffaele, Squeri, Carlo, Signorelli, Roberta, Siliquini, Rosella, Alfano, Elisa, Buttinelli, Rosaria, Cappadona, Placido, D’Agati, Cristina, Genovese, Gabriele, Giubbini, Giuliani, Anna R., Marco, Golfera, Davide, Gori, Giuseppe Di Martino, Massimi, Azzurra, Anna, Odone, Francesca, Quattrocolo, Fabrizio, Stracci, Gianluca, Voglino, Gemma, Zocco, Bert, F., Olivero, E., Rossello, P., Gualano, M. R., Castaldi, S., Damiani, G., D’Errico, M. M., Di Giovanni, P., Fantini, M. P., Fabiani, L., Gabutti, G., Loperto, I., Marranzano, M., Masanotti, G., Nante, N., Rosso, A., Squeri, R., Signorelli, C., Siliquini, R., Alfano, R., Buttinelli, E., Cappadona, R., D’Agati, P., Genovese, C., Giubbini, G., Giuliani, A. R., Golfera, M., Gori, D., Di Martino, G., Massimi, A., Odone, A., Quattrocolo, F., Stracci, F., Voglino, G., and Zocco, G.
- Subjects
knowledge ,medicine.medical_specialty ,Health Knowledge, Attitudes, Practice ,family ,physicians ,MEDLINE ,Sample (statistics) ,health personnel ,NO ,educational status ,03 medical and health sciences ,0302 clinical medicine ,vaccine ,030225 pediatrics ,medicine ,Humans ,vaccine safety ,030212 general & internal medicine ,Settore MED/42 - IGIENE GENERALE E APPLICATA ,Socioeconomic status ,vaccine, pregnancy, knowledge, belief ,pregnancy ,internet ,vaccination ,vaccines ,health care systems ,misconceptions ,business.industry ,Significant difference ,Public Health, Environmental and Occupational Health ,Infant ,Odds ratio ,pregnancy, educational status, health personnel, internet, physicians, family, vaccination, vaccines, health care systems, vaccine safety, misconceptions ,Confidence interval ,Vaccination ,Europe ,Italy ,Family medicine ,Female ,Pregnant Women ,Healthcare service ,business ,belief - Abstract
Background Vaccine hesitancy is an emerging phenomenon in European countries and leads to decreasing trends in infant vaccine coverage. The aim of this study was to analyze the level of confidence and correct awareness about immunizations, which are crucial for the success of vaccination programmes. Methods As part of the NAVIDAD multicentre study, we examined vaccination confidence and complacency among a sample of 1820 pregnant women from 14 Italian cities. The questionnaire assessed the interviewee's knowledge, beliefs and misconceptions, as well as their socioeconomic status, information sources about vaccines and confidence in the Italian National Healthcare Service. Results Only 9% of women completely believed to the efficacy, necessity and safety of vaccinations. Almost 20% of them had misconceptions on most of the themes. There was a significant difference in the level of knowledge considering educational level: women with a high educational level have less probability of obtaining a low knowledge score (odds ratio (OR) 0.43 [95% confidence interval (CI) 0.34–0.54]). The level of knowledge was also influenced by the sources of information: women who received information from their general practitioner (GP) and from institutional websites had a significantly lower chance of having misconceptions (OR 0.74 [95% CI 0.58–0.96]; OR 0.59 [95% CI 0.46–0.74]). Finally, the results underlined the influence of trust in healthcare professional information on the likelihood of having misconceptions (OR 0.49 [95% CI 0.27–0.89]). Conclusions The data suggest the efficacy of GPs and institutional websites as a source of information to contrast misconceptions and underline the importance of confidence in the healthcare system to increase complacency and confidence in vaccines.
- Published
- 2020
30. Humoral response to 2-dose BNT162b2 mRNA vaccine for Covid-19 in liver transplant recipients
- Author
-
Maria Guarino, Ilaria Esposito, Giuseppe Portella, Valentina Cossiga, Ilaria Loperto, Luca Pignata, Raffaella Tortora, Maria Rosaria Attanasio, Michele Cennamo, Mario Capasso, Daniela Terracciano, Francesco Maria Cutolo, Alfonso Galeota Lanza, Raffaele Lieto, Sarah di Somma, Francesco Paolo Picciotto, and Filomena Morisco
- Subjects
Hepatology ,Gastroenterology - Published
- 2022
- Full Text
- View/download PDF
31. AF.93 COVID-19 IN LIVER TRANSPLANT RECIPIENTS: AN ITALIAN CASE-CONTROL DOUBLE-CENTER STUDY
- Author
-
Michele Pier Luca Guarino, M. Capasso, V. Cozza, L. De Coppi, Valentina Cossiga, Ilaria Loperto, F.P. Picciotto, R. Ortolani, I. Esposito, Giuseppina Pontillo, Andrea Fiorentino, Filomena Morisco, G.G. Di Costanzo, and L. Pignata
- Subjects
2019-20 coronavirus outbreak ,Pediatrics ,medicine.medical_specialty ,Hepatology ,Coronavirus disease 2019 (COVID-19) ,Liver ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Gastroenterology ,medicine ,Center (algebra and category theory) ,business ,Abstracts of the 27th National Congress of Digestive Diseases 2021 – FISMAD - Published
- 2021
32. Prevalence of and risk factors for HBV infection in a metropolitan Southern Italian area: Evidence for the effectiveness of universal Hepatitis B vaccination
- Author
-
Tommaso Stroffolini, Flavia Lucia Lombardo, Ilaria Loperto, Silvia Camera, Filomena Morisco, Nicola Caporaso, L. Donnarumma, Valentina Cossiga, Maria Guarino, Morisco, Filomena, Stroffolini, Tommaso, Lombardo, Flavia Lucia, Guarino, Maria, Camera, Silvia, Cossiga, Valentina, Donnarumma, Laura, Loperto, Ilaria, and Caporaso, Nicola
- Subjects
Adult ,Male ,HBsAg ,medicine.medical_specialty ,Pediatrics ,Epidemiology ,Population ,Logistic regression ,03 medical and health sciences ,0302 clinical medicine ,Residence Characteristics ,Risk Factors ,Seroepidemiologic Studies ,Poverty Areas ,Prevalence ,Humans ,Medicine ,030212 general & internal medicine ,Cities ,Hepatitis B Antibodies ,education ,Socioeconomic status ,education.field_of_study ,Hepatitis B Surface Antigens ,Hepatology ,business.industry ,Vaccination ,Age Factors ,Gastroenterology ,Middle Aged ,Hepatitis B ,medicine.disease ,Italy ,Social Class ,Educational Status ,Female ,030211 gastroenterology & hepatology ,Residence ,Risk factor ,business ,Demography - Abstract
Available data on HBV prevalence in Italy are outdated and assessed with studies conducted in small towns. We aimed to evaluate prevalence of and risk factors for HBV infection in the metropolitan area of Naples, 24 years after the introduction of mass vaccination campaign against Hepatitis B in Italy.A random systematic sample of the adult general population of Naples was selected from the register of 3 general practitioners in 3 different socio-economic districts. Independent predictors of the likelihood of HBV infection were identified by logistic regression analysis.Among 900 selected subjects, 772 (85.8%) participated in the study. The overall HBsAg and anti-HBc prevalences were 1.7% and 14.4%, respectively. Both markers were more likely detected in the district at low socioeconomic status than in those at medium-high status (p0.01). Anti-HBc prevalence linearly increased from 0% in subjects 30 years old or younger to 28.0% in those older than 60 years of age (p0.01). At multivariate analysis, age60 years (OR3.38; 95%CI:1.98-5.74), low socioeconomic district of residence (OR3.26; 95%CI:1.72-6.18), and low educational qualification (OR2.73; 95%CI:1.45-5.16) were independent predictors of anti-HBc positivity.Differences in socioeconomic conditions have played a major role in the past spread of HBV infection in Naples. Hepatitis B vaccination has resulted very effectively in preventing HBV infection, regardless of the district of residence, as none of the subjects in the vaccinated cohorts was exposed to the infection.
- Published
- 2017
- Full Text
- View/download PDF
33. Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence
- Author
-
Ilaria Loperto, Andrea Simonetti, Antonio Nardone, Maria Triassi, Loperto, I., Simonetti, A., Nardone, A., and Triassi, M.
- Subjects
Trivalent influenza vaccine ,Squalene ,Common disease ,Cost-Benefit Analysis ,030231 tropical medicine ,Immunology ,Population ,MF59 ,Polysorbates ,Review ,Antibodies, Viral ,adjuvated ,Seasonal influenza ,03 medical and health sciences ,0302 clinical medicine ,systematic review ,Adjuvants, Immunologic ,Risk Factors ,Environmental health ,vaccine ,Influenza, Human ,Immunology and Allergy ,Medicine ,Humans ,030212 general & internal medicine ,education ,health care economics and organizations ,Aged ,Pharmacology ,Aged, 80 and over ,education.field_of_study ,trivalent ,business.industry ,Vaccination ,Age Factors ,economic evidence ,Influenza ,Influenza Vaccines ,older age ,business ,Economic evidence - Abstract
Seasonal influenza is a very common disease. Yearly vaccination of at-risk population groups is a well-recognized cost-effective/cost-saving preventive measure. It is, however, unclear which available alternative has the most favorable economic profile. Some available options are: trivalent (TIV) and quadrivalent (QIV) inactivated vaccines, adjuvanted TIV (aTIV). Because of immunosenescence, aTIV has been specifically developed for elderly. The present study aimed at assessing the available evidence of aTIV use in elderly from the economic perspective. A systematic literature review targeting aTIV economic evaluations in adults aged ≥65 years was performed using Medline via Ovid, Embase, DARE and NHS/EED. Of a total of 3,654 papers screened, 18 studies (13 full papers, 5 conference abstracts) were included. It emerged that compared with both non-vaccination or non-adjuvanted vaccines, aTIV was cost-effective or cost-saving. The vaccinations strategies incorporating aTIV based on age and/or risk profile are associated with the most favorable economic outcomes.
- Published
- 2019
34. Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decades
- Author
-
Filomena Morisco, Nicola Caporaso, Tommaso Stroffolini, Ilaria Loperto, Alessia De Feo, Maria Guarino, Flavia Lucia Lombardo, and Valentina Cossiga
- Subjects
Pediatrics ,medicine.medical_specialty ,education.field_of_study ,Multivariate analysis ,business.industry ,Population ,Systematic sampling ,Hepatitis C ,medicine.disease ,Logistic regression ,Virology ,03 medical and health sciences ,0302 clinical medicine ,Infectious Diseases ,Cohort ,Epidemiology ,medicine ,030211 gastroenterology & hepatology ,030212 general & internal medicine ,education ,business ,Socioeconomic status ,Demography - Abstract
Data on the prevalence of HCV infection in Italy are often outdated and from non-urban populations. This study assessed the prevalence and risk factors for HCV infection in a large metropolitan area in southern Italy. A random 1:3 systematic sample of the adult general population of Naples was selected from three general practitioner patient registers in three different city districts. Socioeconomic indicators and risk factors for HCV infection were collected. Anti-HCV and HCV-RNA assays were performed. Logistic regression analysis was used to identify independent predictors of HCV infection. Of 1,500 randomly selected subjects, 1,315 (87.7%) participated in the study. Forty subjects (3.0%; 95%CI: 2.1-4.0) were anti-HCV-positive, with HCV-RNA detected by PCR in 31 (77.5%) of these. Anti-HCV prevalence increased with age, peaking (8.2%) in people born during the years 1945-1955. It was 1.7% in people residing in the better socioeconomic districts; but 5.7% in those residing in the district with lower socioeconomic status (P < 0.01). In multivariate analysis, age ≥60 years (OR 2.8, 95%CI: 1.3-6.1) and lower educational level (OR 3.6; 95%CI: 1.4-9.3), which is a proxy of low socioeconomic status, were the only independent predictors of the likelihood of anti-HCV positivity. Overall, 22.5% of anti-HCV positive subjects were previously unaware of their status. In the large city of Naples, infection with HCV is most common in people aged older than 60 years. Differences in socioeconomic conditions have played an important role in the spread of this infection. HCV positive subjects born during the years 1945-1955 are those who may benefit, to a greater extent, to be identified in order to receive the new effective therapy. J. Med. Virol. 89:291-297, 2017. © 2016 Wiley Periodicals, Inc.
- Published
- 2016
- Full Text
- View/download PDF
35. Osteoporosis across chronic liver disease
- Author
-
Silvia Camera, Ilaria Loperto, A. Colao, Filomena Morisco, Maria Guarino, Valentina Cossiga, C. Di Somma, Nicola Caporaso, Guarino, Maria, Loperto, Ilaria, Camera, Silvia, Cossiga, V, DI SOMMA, Carolina, Colao, Annamaria, Caporaso, Nicola, and Morisco, Filomena
- Subjects
medicine.medical_specialty ,Bone disease ,Endocrinology, Diabetes and Metabolism ,Osteoporosis ,030209 endocrinology & metabolism ,Disease ,Chronic liver disease ,03 medical and health sciences ,Liver disease ,0302 clinical medicine ,Bone Density ,medicine ,Humans ,Intensive care medicine ,Osteomalacia ,business.industry ,Liver Diseases ,medicine.disease ,Surgery ,Metabolic Bone Disorder ,Osteopenia ,Bone Diseases, Metabolic ,Fracture ,Chronic Disease ,Quality of Life ,030211 gastroenterology & hepatology ,business - Abstract
Osteoporosis is a complication of chronic liver disease, with impact on morbidity, quality of life, and survival. The progress of medicine and the new therapies stretched the disease's natural history and improved the survival of patients with liver disease. So, it is fundamental to make better the quality of life and to prevent complications. Metabolic bone disorders are common complications of chronic liver disease (CLD). Patients with CLD have an increased risk of bone fractures, with significant impact on morbidity, quality of life, and even on survival. Bone diseases, including osteomalacia, osteoporosis, and osteopenia, are frequently observed in many types of liver disease. The pathogenesis of damage and the mechanisms of bone loss are different in relation to the specific liver disease. The relevance of these conditions induced many authors to create a new nosographic entity known as "hepatic osteodystrophy", although this term is rarely used anymore and it is now commonly referred to as osteopenia or osteoporosis associated with chronic liver disease. This review is based on the personal experiences of the authors and upon research done of the available literature on this subject matter. The authors searched the PubMed database for publications containing the term "liver disease" in combination with "bone disease", "hepatic osteodistrophy", "osteoporosis", "osteopenia", "osteomalacia", and "fractures". They selected publications from the past 10 years but did not exclude older seminal publications, especially for colestatic liver diseases. This review of literature shows that osteoporosis crosses all CLD. It is important to underline that the progress of medicine and the new therapies stretched the disease's natural history and improved the survival of patients with CLD. It is fundamental to make better the quality of life and it is mandatory to prevent complications and in particular the osteoporotic ones, especially fractures.
- Published
- 2016
- Full Text
- View/download PDF
36. PDG80 Healthcare Resource Utilization and Costs for Extended Interval Dosing of Natalizumab in Relapsing Remitting Multiple Sclerosis
- Author
-
Ilaria Loperto, Raffaele Palladino, Maria Triassi, Marcello Moccia, S. Masera, L. Santoni, V Brescia Morra, and Antonio Carotenuto
- Subjects
medicine.medical_specialty ,business.industry ,Health Policy ,Multiple sclerosis ,Public Health, Environmental and Occupational Health ,medicine.disease ,Extended interval dosing ,Natalizumab ,Relapsing remitting ,Health care ,medicine ,Intensive care medicine ,business ,Resource utilization ,medicine.drug - Published
- 2020
- Full Text
- View/download PDF
37. Attitudes towards compulsory vaccination in Italy: Results from the NAVIDAD multicentre study
- Author
-
A. Miduri, F Quattrocolo, Francesca Pennino, F. Di Donna, E Olivero, Azzurra Massimi, Maria Rosaria Gualano, C de Waure, Fabrizio Stracci, Ilaria Loperto, P Di Giovanni, Nicola Nante, Antonio Giuliani, Marina Marranzano, Emilia Prospero, LG Sisti, C. Signorelli, Giuseppe Michele Masanotti, Silvana Castaldi, G Voglino, M. Golfera, Roberta Siliquini, Raffaele Squeri, Fabrizio Bert, P Rossello, M P Fantini, M. M. D'Errico, P. Greco, A. Stefanati, Annalisa Rosso, C Genovese, Davide Gori, G Di Martino, E. Buttinelli, G. Zappalà, Gualano, M. R., Bert, F., Voglino, G., Buttinelli, E., D'Errico, M. M., De Waure, C., Di Giovanni, P., Fantini, M. P., Giuliani, A. R., Marranzano, M., Masanotti, G., Massimi, A., Nante, N., Pennino, F., Squeri, R., Stefanati, A., Signorelli, C., Siliquini, R., Castaldi, S., Di Donna, F., Di Martino, G., Genovese, C., Golfera, M., Gori, D., Greco, P., Loperto, I., Miduri, A., Olivero, E., Prospero, E., Quattrocolo, F., Rossello, P., Rosso, A., Sisti, L. G., Stracci, F., Zappalà, G., Gualano, Mr, Bert, F, Voglino, G, Buttinelli, E, D'Errico, Mm, De Waure, C, Di Giovanni, P, Fantini, Mp, Giuliani, Ar, Marranzano, M, Masanotti, G, Massimi, A, Nante, N, Pennino, F, Squeri, R, Stefanati, A, Signorelli, C, Siliquini, R, Gualano, M R, D'Errico, M M, Fantini, M P, and Giuliani, A R
- Subjects
Health Knowledge, Attitudes, Practice ,Multivariate analysis ,Cross-sectional study ,Immunology and Microbiology (all) ,Attitudes ,Italy ,Mandatory vaccination ,Multicentre survey ,Pregnancy ,Vaccine hesitancy ,Molecular Medicine ,Veterinary (all) ,Public Health, Environmental and Occupational Health ,Infectious Diseases ,Mandatory Programs ,Socioeconomic Factor ,Heterogeneous-Nuclear Ribonucleoproteins ,Health personnel ,0302 clinical medicine ,Medicine ,030212 general & internal medicine ,Multivariate Analysi ,Practice ,Immunization Program ,Health Knowledge ,Mandatory Program ,Vaccination ,Adolescent ,Adult ,Cross-Sectional Studies ,Female ,Health Personnel ,Humans ,Multivariate Analysis ,Pregnant Women ,Socioeconomic Factors ,Immunization Programs ,Public Health ,Human ,medicine.medical_specialty ,Socio-culturale ,03 medical and health sciences ,030225 pediatrics ,Socioeconomic status ,Cross-Sectional Studie ,Mandatory vaccination, Vaccine hesitancy, Pregnancy, Multicentre survey, Italy ,General Veterinary ,General Immunology and Microbiology ,Health professionals ,business.industry ,Environmental and Occupational Health ,Attitude ,Family medicine ,Heterogeneous-Nuclear Ribonucleoprotein ,Healthcare service ,business - Abstract
Background: Vaccine hesitancy is a considerable issue in European countries and leads to low coverage rates. After a long debate, Italy has made vaccination mandatory for admission to its schools.Methods: In the NAVIDAD study (a cross-sectional multicentre study), a 63-item questionnaire was administered to 1820 pregnant women from 15 Italian cities. The questionnaire assessed the interviewee's opinion on mandatory vaccines, as well as their socioeconomic status, sources of information about vaccines, confidence in the Italian National Healthcare Service (NHS), and intention to vaccinate their newborn.Results: Information sources play a key role in determining the opinion on restoration of mandatory vaccines; in particular, women who obtained information from anti-vaccination movements are less likely to accept the vaccines (OR: 0.35, 95% CI: 0.21-0.58, p < 0.001). Women who had confidence in healthcare professional information agreed more on mandatory vaccination than did the other women (OR: 2.66, 95% CI: 1.62-4.36, p < 0.001); those who perceived that healthcare professionals have economic interest in child immunization and who declared that healthcare providers inform only on vaccinations benefits not on risks were less likely to agree on compulsory vaccination (OR: 0.66, CI 95%: 0.46-0.96, p = 0.03; OR: 0.66, CI 95%: 0.46-0.95, p = 0.03, respectively).Conclusion: Information sources and confidence towards health professionals are the main determinants of acceptance of mandatory vaccine restoration. To increase the acceptability of the restoration and reduce vaccine hesitancy, these aspects need to be strengthened.
- Published
- 2018
- Full Text
- View/download PDF
38. Vitamin D levels and chronic hepatitis C
- Author
-
Annamaria Colao, Francesco Auriemma, G. Mazzone, R. Granata, Federica Cariati, Vincenzo Lembo, Carolina Di Somma, Ilaria Loperto, Filomena Morisco, Manila Rubino, Maria Guarino, L. Donnarumma, Claudia Pivonello, Nicola Caporaso, Anna Mariniello, Morisco, Filomena, Annamaria, Colao, Guarino, Maria, Vincenzo, Lembo, Rocco, Granata, Laura, Donnarumma, Francesco, Auriemma, Anna, Mariniello, Giovanna, Mazzone, Carolina Di Somma, Manila, Rubino, Federica, Cariati, Pivonello, Claudia, Ilaria, Loperto, and Caporaso, Nicola
- Subjects
medicine.medical_specialty ,education.field_of_study ,Nutrition and Dietetics ,Cirrhosis ,medicine.diagnostic_test ,business.industry ,Endocrinology, Diabetes and Metabolism ,Population ,Parathyroid hormone ,chemistry.chemical_element ,Calcium ,medicine.disease ,vitamin D deficiency ,Endocrinology ,chemistry ,Internal medicine ,Immunoassay ,Vitamin D and neurology ,Medicine ,business ,education ,Homeostasis - Abstract
summary Background and purpose: Vitamin D (VitD) is involved in homeostasis of calcium and interacts with parathyroid hormone (PTH). Low levels of VitD in chronic liver diseases, in particular in chronic hepatitis C (CHC) was reported. We aimed to determine the levels of VitD and PTH in patients with CHC without cirrhosis to evaluate the disturbance of VitD-PTH axis. Methods: We conduced a caseecontrol studyenrolling59patients with CHCand 59 controls. We determined serum concentration of VitD, PTH, calcium and phosphate. VitD was quantified by chemiluminescence immunoassay. PTH was measured by 2-site chemiluminescent enzyme-labeled immunoassay. Results: The mean value of VitD was 26.28 and 28.43 ng/ml in HCV patients and controls respectively (p < 0.31). The distribution of the severity of VitD deficit in HCV population was the following: 5% had a deficiency, 64% had an insufficiency and 31% had normal levels. No difference was observed in the control group (p < 0.9). The mean value of PTH was 17.04 and 26.7 pg/ml in HCV patients and controls respectively (p < 0.0004). Calcium and phosphate were in the range of normality in both. Conclusions: The VitD deficit is similar in HCV-patients and general population of the same geographic area. Therefore we can state that this is a public health problem.
- Published
- 2013
- Full Text
- View/download PDF
39. Lack of evidence that adherence to standard of care therapy improves survival in subjects with hepatocellular carcinoma in clinical practice
- Author
-
Ivan Gentile, Tommaso Stroffolini, Ilaria Loperto, Francesco Auriemma, Maria Guarino, Nicola Caporaso, Filomena Morisco, and Flavia Lucia Lombardo
- Subjects
medicine.medical_specialty ,Standard of care ,Proportional hazards model ,business.industry ,Mortality rate ,medicine.disease ,Virology ,BCLC Stage ,Surgery ,Clinical Practice ,Infectious Diseases ,Internal medicine ,Hepatocellular carcinoma ,Tumor stage ,medicine ,Prospective cohort study ,business - Abstract
Currently, the BCLC classification, which links tumor stage with treatment option, is the standard system for clinical management of HCC. Thus far, this approach has been considered the standard of care worldwide. This study aimed to evaluate the survival of patients with HCC according to the BCLC Stage, surveillance, and adherence to standards of care. A 3-year prospective study enrolled 92 consecutive patients with HCC in the Gastroenterology Unit of the University of Naples “Federico II”. Predictors of the likelihood of death were evaluated by the multivariate Cox model. Forty out of 92 (43%) subjects died during three years of follow up. The overall mortality rate per 100 person–years was 16.7, while the mortality rate for hepatic causes was only 14.2; it was lower in subjects under surveillance (11.4 vs. 28.2), in subjects adherent to standards of care (12.0 vs. 21.1), and in those who were in a better BCLC stage (10.6 vs. 45.8). The multivariate Cox model showed that advanced BCLC stage (HR 4.1, 95%C.I. = 1.8–9.4) was the sole independent predictor of the likelihood of mortality. In this regard, we observed lack of evidence that the adherence to the BCLC recommendations reduces the mortality of patients with HCC; and that the BCLC system cannot be accepted as a “commandment” to be invariably followed in everyday practice. Strategies to help improve adherence to international guidelines for HCC in clinical practice are required. J. Med. Virol. 87:1368–1376, 2015. © 2015 Wiley Periodicals, Inc.
- Published
- 2015
- Full Text
- View/download PDF
40. Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decades
- Author
-
Filomena, Morisco, Ilaria, Loperto, Tommaso, Stroffolini, Flavia Lucia, Lombardo, Valentina, Cossiga, Maria, Guarino, Alessia, De Feo, and Nicola, Caporaso
- Subjects
Adult ,Male ,Urban Population ,Age Factors ,Hepatitis C Antibodies ,Middle Aged ,Hepatitis C ,Education ,Italy ,Socioeconomic Factors ,Risk Factors ,Surveys and Questionnaires ,Prevalence ,Animals ,Humans ,RNA, Viral ,Female ,Aged - Abstract
Data on the prevalence of HCV infection in Italy are often outdated and from non-urban populations. This study assessed the prevalence and risk factors for HCV infection in a large metropolitan area in southern Italy. A random 1:3 systematic sample of the adult general population of Naples was selected from three general practitioner patient registers in three different city districts. Socioeconomic indicators and risk factors for HCV infection were collected. Anti-HCV and HCV-RNA assays were performed. Logistic regression analysis was used to identify independent predictors of HCV infection. Of 1,500 randomly selected subjects, 1,315 (87.7%) participated in the study. Forty subjects (3.0%; 95%CI: 2.1-4.0) were anti-HCV-positive, with HCV-RNA detected by PCR in 31 (77.5%) of these. Anti-HCV prevalence increased with age, peaking (8.2%) in people born during the years 1945-1955. It was 1.7% in people residing in the better socioeconomic districts; but 5.7% in those residing in the district with lower socioeconomic status (P 0.01). In multivariate analysis, age ≥60 years (OR 2.8, 95%CI: 1.3-6.1) and lower educational level (OR 3.6; 95%CI: 1.4-9.3), which is a proxy of low socioeconomic status, were the only independent predictors of the likelihood of anti-HCV positivity. Overall, 22.5% of anti-HCV positive subjects were previously unaware of their status. In the large city of Naples, infection with HCV is most common in people aged older than 60 years. Differences in socioeconomic conditions have played an important role in the spread of this infection. HCV positive subjects born during the years 1945-1955 are those who may benefit, to a greater extent, to be identified in order to receive the new effective therapy. J. Med. Virol. 89:291-297, 2017. © 2016 Wiley Periodicals, Inc.
- Published
- 2016
41. Lack of evidence that adherence to standard of care therapy improves survival in subjects with hepatocellular carcinoma in clinical practice
- Author
-
Maria, Guarino, Tommaso, Stroffolini, Flavia Lucia, Lombardo, Ilaria, Loperto, Francesco, Auriemma, Ivan, Gentile, Nicola, Caporaso, and Filomena, Morisco
- Subjects
Aged, 80 and over ,Male ,Carcinoma, Hepatocellular ,Liver Neoplasms ,Standard of Care ,Middle Aged ,Survival Analysis ,Treatment Outcome ,Italy ,Humans ,Female ,Guideline Adherence ,Prospective Studies ,Aged ,Follow-Up Studies - Abstract
Currently, the BCLC classification, which links tumor stage with treatment option, is the standard system for clinical management of HCC. Thus far, this approach has been considered the standard of care worldwide. This study aimed to evaluate the survival of patients with HCC according to the BCLC Stage, surveillance, and adherence to standards of care. A 3-year prospective study enrolled 92 consecutive patients with HCC in the Gastroenterology Unit of the University of Naples "Federico II". Predictors of the likelihood of death were evaluated by the multivariate Cox model. Forty out of 92 (43%) subjects died during three years of follow up. The overall mortality rate per 100 person-years was 16.7, while the mortality rate for hepatic causes was only 14.2; it was lower in subjects under surveillance (11.4 vs. 28.2), in subjects adherent to standards of care (12.0 vs. 21.1), and in those who were in a better BCLC stage (10.6 vs. 45.8). The multivariate Cox model showed that advanced BCLC stage (HR 4.1, 95% C.I. = 1.8-9.4) was the sole independent predictor of the likelihood of mortality. In this regard, we observed lack of evidence that the adherence to the BCLC recommendations reduces the mortality of patients with HCC; and that the BCLC system cannot be accepted as a "commandment" to be invariably followed in everyday practice. Strategies to help improve adherence to international guidelines for HCC in clinical practice are required.
- Published
- 2015
42. Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease
- Author
-
Francesco Auriemma, Maria Guarino, Stefano Sansone, Fabiana Castiglione, Ilaria Loperto, Nicola Caporaso, Matilde Rea, Antonio Rispo, Filomena Morisco, Sansone, S, Guarino, Maria, Castiglione, Fabiana, Rispo, A, Auriemma, F, Loperto, I, Rea, M, Caporaso, Nicola, and Morisco, Filomena
- Subjects
Risk ,medicine.medical_specialty ,Hepatitis B virus ,medicine.medical_treatment ,Fulminant ,Hepacivirus ,medicine.disease_cause ,Inflammatory bowel disease ,Immunocompromised Host ,medicine ,Prevalence ,Humans ,Topic Highlight ,Intensive care medicine ,Hepatitis ,Immunosuppression Therapy ,Biological Products ,business.industry ,Gastroenterology ,Immunosuppression ,General Medicine ,Hepatitis C ,Hepatitis B ,medicine.disease ,Inflammatory Bowel Diseases ,Immunology ,Virus Activation ,business ,Viral hepatitis ,Immunosuppressive Agents - Abstract
In recent years, a number of case reports and clinical studies have highlighted the risk of hepatitis B and C virus reactivation in patients with inflammatory bowel disease who are treated with immunosuppressive drugs. The cases of viral hepatitis reactivation that have been reported are characterized by a wide range of clinical manifestations, from viremia without clinically relevant manifestations to fulminant life-threatening hepatitis. The development and dissemination of biological immunosuppressive drugs have led to a significant increase in the number of reports of interest to physicians in a variety of clinical settings. On this topic, there have been a number of published guidelines and reviews that have collected the available evidence, providing recommendations on prophylactic and therapeutic strategies and methods for monitoring patients at risk. However, it should be noted that, to date, very few clinical studies have been published, and most of the recommendations have been borrowed from other clinical settings. The published studies are mostly retrospective and are based on very heterogeneous populations, using different therapeutic and prophylactic regimens and obtaining conflicting results. Thus, it seems clear that it is desirable to concentrate our efforts on prospective studies, not conducting further reviews of the literature in the continued absence of new evidence.
- Published
- 2013
43. Prevalence and risk factors for hepatitis C virus infection in a metropolitan area of Italy
- Author
-
Valentina Cossiga, Tommaso Stroffolini, Nicola Caporaso, Ilaria Loperto, Michele Pier Luca Guarino, Filomena Morisco, A. De Feo, and Flavia Lucia Lombardo
- Subjects
Hepatology ,business.industry ,Environmental health ,Hepatitis C virus ,Gastroenterology ,Medicine ,business ,medicine.disease_cause ,Metropolitan area - Published
- 2016
- Full Text
- View/download PDF
44. P.17.7 REACTIVATION OF HBV INFECTION IN PATIENTS WITH LYMPHOMA TREATED WITH CHEMOTHERAPY CONTAINING OR NOT RITUXIMAB
- Author
-
Nicola Caporaso, A. Vitiello, Matilde Rea, Ilaria Loperto, Filomena Morisco, Marco Picardi, Valentina Cossiga, Marta Raimondo, E. Clery, Michele Pier Luca Guarino, C. Ferraiuoli, L. Donnarumma, Novella Pugliese, and Fabrizio Pane
- Subjects
Oncology ,medicine.medical_specialty ,Chemotherapy ,Hepatology ,business.industry ,medicine.medical_treatment ,Gastroenterology ,medicine.disease ,Lymphoma ,Internal medicine ,medicine ,Rituximab ,In patient ,business ,medicine.drug - Published
- 2014
- Full Text
- View/download PDF
45. P.17.10 ADHERENCE TO TRIPLE THERAPY IN HCV
- Author
-
Nicola Caporaso, Michele Pier Luca Guarino, S. Camera, G.G. Di Costanzo, F. Lampasi, R. Granata, Valentina Cossiga, M.T. Tartaglione, Ilaria Loperto, Filomena Morisco, C. Ferraiuoli, and E. Clery
- Subjects
Oncology ,medicine.medical_specialty ,Hepatology ,business.industry ,Internal medicine ,Gastroenterology ,Medicine ,business - Published
- 2014
- Full Text
- View/download PDF
46. P0369 : Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in HCC patients
- Author
-
Concetta Tuccillo, R. Granata, Francesco Auriemma, Nicola Caporaso, Filomena Morisco, G.G. Di Costanzo, Ilaria Loperto, Andrea Gallotta, Maria Guarino, R. Tortora, and Giorgio Fassina
- Subjects
medicine.medical_specialty ,Cirrhosis ,Hepatology ,business.industry ,medicine.disease ,Lower risk ,Gastroenterology ,MERTK Gene ,Liver disease ,Internal medicine ,Genotype ,medicine ,Biomarker (medicine) ,SNP ,business - Abstract
s / Digestive and Liver Disease 46S (2014) e136–e141 e137 all 248 patients had reached HBV undetectability
- Published
- 2015
- Full Text
- View/download PDF
47. P.18.23 SCCA-IgM: A BIOMARKER TO MONITOR THE OUTCOME OF THERAPY WITH SORAFENIB IN ADVANCED HCC
- Author
-
Nicola Caporaso, Francesco Auriemma, R. Tortora, Michele Pier Luca Guarino, C. Ferraiuoli, Ilaria Loperto, L. Beneduce, Concetta Tuccillo, Filomena Morisco, and G.G. Di Costanzo
- Subjects
Sorafenib ,Oncology ,medicine.medical_specialty ,Hepatology ,business.industry ,Internal medicine ,Gastroenterology ,medicine ,Biomarker (medicine) ,business ,medicine.drug - Published
- 2013
- Full Text
- View/download PDF
48. P.02.12 HIGH FAT DIET AND GUT PERMEABILITY: THE ROLE OF DECAFFEINATED COFFEE
- Author
-
Ilaria Loperto, Filomena Morisco, G. Mazzone, Nicola Caporaso, Michele Pier Luca Guarino, Giuseppe D'Argenio, E. Clery, C. Ferraiuoli, Vincenzo Fogliano, Valentina Cossiga, Paola Vitaglione, Vincenzo Lembo, and A. Vitiello
- Subjects
Hepatology ,business.industry ,Gastroenterology ,Gut permeability ,Medicine ,High fat diet ,Food science ,business ,Decaffeinated coffee - Published
- 2014
- Full Text
- View/download PDF
49. Reactivation of hepatitis B virus in HBsAg-negative HBcAb-positive patients with psoriasis undergoing immunosuppressive therapy
- Author
-
S La Bella, Francesco Auriemma, Michele Pier Luca Guarino, Fabrizio Ayala, E. Clery, L. Di Costanzo, R. Granata, L. Donnarumma, C. Ferraiuoli, N. Balato, Filomena Morisco, Ilaria Loperto, and Nicola Caporaso
- Subjects
Hepatitis B virus ,Hbsag negative ,Hepatology ,business.industry ,Psoriasis ,Gastroenterology ,medicine ,medicine.disease ,business ,medicine.disease_cause ,Virology - Published
- 2014
- Full Text
- View/download PDF
50. Su1001 Circulating Scca-IgM Complex Is an Useful Biomarker to Monitor HCC Therapy
- Author
-
Francesco Auriemma, Raffaella Tortora, Concetta Tuccillo, Luca Beneduce, Giovan Giuseppe Di Costanzo, Ilaria Loperto, Maria Guarino, Filomena Morisco, Carmine Ferraiuoli, and Nicola Caporaso
- Subjects
Genetically modified mouse ,Hepatology ,biology ,Proliferation index ,Transgene ,Gastroenterology ,Wnt signaling pathway ,HCCS ,medicine.disease_cause ,Receptor tyrosine kinase ,SULF1 ,biology.protein ,Cancer research ,medicine ,Carcinogenesis - Abstract
Background and Aims: Using in vitro cell culture and in vivo xenograft mouse models, we have previously shown that the heparan sulfate-degrading endosulfatase SULF1 functions as a tumor suppressor in established hepatocellular carcinoma cell lines by abrogating receptor tyrosine kinase signaling. In contrast, whole genome gene expression analysis of resected human HCCs showed increased expression of SULF1 in 70% of primary HCCs; and SULF1 expression in primary HCCs has been associated with activation of the oncogenic Wnt/β-catenin pathway. Here we report for the first time the results of DEN-induced hepatocarcinogenesis in a hepatocyte-specific transgenic Sulf1 mouse model in which the Sulf1 gene is driven by the transthyretin promoter. The effect of Sulf1 transgenesis on Wnt/ β-catenin activation was assessed. Methods: Liver carcinogenesis was induced in wild-type or hepatocyte-specific Sulf1 transgenic mice by intraperitoneal injection of 15 mg/kg of the liver carcinogen diethylnitrosamine (DEN) at 14 days after birth. Mice were sacrificed at 8 months of age and the harvested livers were examined for weight, tumor size and number. Cell proliferation was assessed using the BrdU proliferation index and Wnt/ β-catenin activation was measured by assessment of β-catenin staining and cytoplasmic-nuclear translocation of β-catenin. Results: Consistent with the observation of increased SULF1 in primary human HCCs, Sulf1 transgenic mice showed increased liver tumorigenesis as demonstrated by tumor number, tumor volume, liver weight/body weight ratio, and BrdU proliferation index. To investigate the mechanism for this, we performed immunohistochemistry for β-catenin. Wnt-β-catenin signaling was increased in Sulf1 transgenic mice compared to wild-type mice, as assessed by both increased β-catenin immunostaining and increased cytoplasmic-nuclear translocation of β-catenin. Conclusions: In contrast to the tumor suppressor effects of SULF1 in established human cell lines, which are mediated by inhibition of the co-receptor function of heparan sulfate in receptor tyrosine kinase signaling, primary HCCs in an in vivo model of DEN-induced HCC in Sulf1 transgenic mice show increased liver tumorigenesis associated with activation ofWnt-β-catenin signaling. This suggests that the effect of Sulf1 in carcinogenesis is context-dependent, but appears to be mediated through oncogenic Wntβ-catenin signaling in the majority of HCCs.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.